investordatabase.org

Angelini Ventures

angeliniventures.com Direct investor

Angelini Ventures is the venture capital firm of Angelini Industries, investing €300 million globally in BioTech and HealthTech companies. It focuses on leveraging technology to improve healthcare and supports entrepreneurs across the company-building journey.

Angelini Ventures is a corporate venture arm headquartered in Rome, Italy. It invests directly in companies, from Series A to Series B, in BioTech and HealthTech. €300 million under management, as it reports.

Layer
Direct investor
Type
Corporate venture
Stage
Series ASeries B
Headquarters
Rome, Italy
Invests in
Europe, North America
Sectors
BioTech, HealthTech
Assets under management
€300 million

Team, as Angelini Ventures publishes it

  • Paolo Di Giorgio CEO and Managing Director
  • Elia Stupka Managing Director
  • Tanja Dowe Managing Director
  • Regina Hodits Managing Director
  • Gabriela Manrique Partner
  • Fabrizio Calisti Medical Director
  • Nils Bottler Principal
  • Cesar Montero Finance Manager
  • Barbara Saulini Executive Assistant
  • Natasa Ralevic Data & Tech Lead
  • Martina Palmese Communications & Sustainability Lead
  • Maya Misra Senior Analyst

Names and roles exactly as listed on angeliniventures.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Angelini Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 7141 · added 2026-09-05 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under